Bing Zhang

Bing Zhang is an Assistant Professor of Clinical Medicine and Molecular Microbiology and Immunology at the University of Southern California. His research focuses on inflammatory bowel disease (IBD), gut microbiome interactions, and connections between gastrointestinal disorders and neurodegenerative conditions like Alzheimer's disease. Dr. Zhang leads investigations into the gut-brain axis, microbial contributions to inflammation, and epidemiological patterns of IBD comorbidities.

His publications demonstrate strong focus areas in:

• Clinical gastroenterology and IBD pathophysiology
• Gut microbiome dynamics in disease states
• Neurodegenerative connections to gastrointestinal inflammation
• Epidemiological studies of IBD comorbidities
• Microbiota transplantation therapies

Recent article trends show expanding research into immunological mechanisms of gut-brain communication, particularly examining how gut bacteria influence neurological outcomes. His work frequently employs large-scale epidemiological analyses, clinical trial data, and molecular characterization of host-microbe interactions.

Awards include:

• USC Zumberge Individual Research Award (2022-2023)
• Gut Journal Top 12 Papers recognition (2021)

Dr. Zhang maintains active clinical research programs examining novel therapeutic approaches for ulcerative colitis and Crohn's disease, with particular attention to microbiota-based interventions and their impact on systemic inflammation.